Vascular endothelial growth factor inhibitors in exudative retinal diseases: overview of recent advances and prospects for further progress
The incidence of blindness due to exudative retinal diseases reduced significantly over the twenty years of the use of anti-vascular endothelial growth factor (VEGF) therapy in ophthalmology. However, despite advances in recent years, current outcomes of anti-VEGF therapy for exudative retinal disea...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Ukrainian Society of Ophthalmologists,
2024-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|